Nitric oxide-20-hydroxyeicosatetraenoic acid interaction in the regulation of K+ channel activity and vascular tone in renal arterioles

Circulation Research

Volumn 83, Issue 11, 1998, Pages 1069-1079

  Sun, Cheng Wen ^a   Alonso Galicia, Magdalena ^a   Taheri, M Reza ^a   Falck, John R ^b   Harder, David R ^a   Roman, Richard J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Arachidonic acid; Cytochrome P450; Renal circulation vascular smooth muscle

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; CYTOCHROME P450; GUANYLATE CYCLASE; HYDROXYICOSATETRAENOIC ACID; NITRIC OXIDE; POTASSIUM ION; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CELL INTERACTION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; KIDNEY ARTERY; KIDNEY CIRCULATION; MALE; MEMBRANE POTENTIAL; NONHUMAN; PATCH CLAMP; POTASSIUM TRANSPORT; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; VASODILATATION;

EID: 0032583140     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.83.11.1069     Document Type: Article

References (53)

1. Navar LG, Inscho EW, Majid DSA, Imig JD, Harrison-Bernard LM, Mitchell KD. Paracrine regulation of the renal microcirculation. Physiol Rev. 1996;76:425-536.
2. Bachmann S, Mundel P. Nitric oxide in the kidney: synthesis, localization, and function. Am J Kidney Dis. 1994;24:112-129.
3. Hu L, Manning RD, Brands SMW. Long-term cardiovascular role of nitric oxide in conscious rats. Hypertension. 1994;23:185-194.
4. Cohen RA, Vanhoutte PM. Endothelium-dependent hyperpolarization. Beyond nitric oxide and cyclic GMP. Circulation. 1995;92:3337-3349.
5. Loscalzo J, Welch G. Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis. 1995;38:87-104.
6. Ca channel antagonists reduce NO donor-mediated relaxation of vascular and tracheal smooth muscle. Am J Physiol. 1995;268:L152-L159.
7. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature. 1994;368:850-853.
8. + channels and contraction of cultured smooth muscle cells of porcine coronary artery. J Pharmacol Exp Ther. 1991;256:371-377.
9. Li PL, Zou AP, Campbell WB. Regulation of potassium channels in coronary arterial smooth muscle by endothelium-derived vasodilators. Hypertension. 1997;29:262-267.
10. + channels are stimulated by cyclic guanosine monophosphate-dependent protein kinase in canine coronary artery smooth muscle cells. Pflugers Arch. 1993;423: 167-172.
11. Carrier GO, Fuchs LC, Winecoff AP, Giulumian AD, White RE. Nitro-vasodilators relax mesenteric microvessels by cGMP-induced stimulation of Ca-activated K channels. Am J Physiol. 1997;273:H76-H84.
12. + channels in cerebral artery smooth muscle cells. Am J Physiol. 1993;265:C299-C303.
13. Archer SL, Huang JM, Hampl V, Nelson DP, Shultz PJ, Weir EK. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci U S A. 1994;91:7583-7587.
14. Olson LJ, Knych ET, Herzig TC, Drewett JG. Selective guanylyl cyclase inhibitor reverses nitric oxide-induced vasorelaxation. Hypertension. 1997;29:254-261.
15. + channels in the vasodilation induced by nitroglycerine, acetylcholine and nitric oxide. J Pharmacol Exp Ther. 1993;267:1327-1335.
16. Collins P, Griffith TM, Henderson AH, Lewis MJ. Endothelium derived relaxing factor alters calcium fluxes in rabbit aorta: a cGMP monophosphate-mediated effect. J Physiol. 1986;381:427-437.
17. ++-pump by nitroglycerin and atrial natriuretic factors of the rabbit aorta contracted by phenylephrine. J Pharmacol Exp Ther. 1993;265:1187-1192.
18. 2+ by sarcoplasmic reticulum in vascular smooth muscle. Circ Res. 1988;62:961-964.
19. Lincoln TM, Komalavilas P, Cornwell TL. Pleiotropic regulation of vascular smooth muscle tone by cyclic-GMP-dependent protein kinase. Hypertension. 1994;23:1141-1147.
20. Najibi S, Cowan CL, Palacino JJ, Cohen RA. Enhanced role of potassium channels in relaxations to acetylcholine in hypercholesterolemic rabbit carotid artery. Am J Physiol. 1994;266:H2061-H2067.
21. Marshall JJ, Wei EP, Kontos HA. Independent blockade of cerebral vasodilation from acetylcholine and nitric oxide. Am J Physiol. 1988;255: H847-H854.
22. Wong WS, Roman CR, Fleisch JH. Differential relaxant responses of guinea-pig lung strips and bronchial rings to sodium nitroprusside: a mechanism independent of cGMP formation. J Pharm Pharmacol. 1995; 47:757-761.
23. Eckman DM, Weinert JS, Buxton IL, Keef KD. Cyclic cGMP-independent relaxation and hyperpolarization with acetylcholine in guinea-pig coronary artery. Br J Pharmacol. 1994;111:1053-1060.
24. Hurshman AR, Marletta MA. Nitric oxide complexes of inducible nitric oxide synthase: Spectral characterization and effect on catalytic activity. Biochemistry. 1995;34:5627-5634.
25. Khatsenko OG, Gross SS, Rifkind AB, Vane JR. Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. Proc Natl Acad Sci U S A. 1993;90: 11147-11151.
26. Wink DA, Osawa Y, Darbyshire JF, Jones CR, Eshenaur SC, Nims RW. Inhibition of cytochromes P450 by nitric oxide and a nitric oxide-releasing agent. Arch Biochem Biophys. 1993;300:115-123.
27. Harder DR, Gebremedhin D, Narayanan J, Jefcoat J, Falck JR, Campbell WB, Roman RJ. Formation and action of a P4504A arachidonic acid metabolite in cat cerebral microvessels. Am J Physiol. 1994;266: H1840-H1845.
28. + channel in renal arterioles. Am J Physiol. 1996;270: R228-R237.
29. Wang MH, Stec DE, Balazy M, Mastyugin V, Yang CS, Roman RJ, Schwartzman ML. Cloning, sequencing, and cDNA-directed expression of the rat renal CYP4A2: arachidonic acid ω-hydroxylation and 11,12-epoxidation by CYP4A2 protein. Arch Biochem Biophys. 1996;336: 240-250.
30. Omura T, Sato R. The carbon monoxide-binding pigment of liver microsomes, I: evidence for its hemoprotein nature. J Biol Chem. 1964; 239:2370-2378.
31. Feelish M, Kubitzek D, Werringloer J. The oxyhemoglobin assay. In: Feelish M, Stamler JS, eds. Methods in NO Research. New York, NY: John Wiley and Sons Ltd; 1996:455-478.
32. Harder DR, Narayanan J, Birks EK, Liard JF, Imig JD, Lombard JH, Lange AR, Roman RJ. Identification of a putative microvascular oxygen sensor. Circ Res. 1996;79:54-61.
33. + channels in rat renal arterioles. Am J Physiol. 1996;270:F69-F81.
34. +-channel activity. Am J Physiol. 1996;270: F822-F832.
35. Gelband GH, Hume JR. Ionic currents in single smooth muscle cells of the canine renal artery. Circ Res. 1992;71:745-758.
36. Gorienko DV, Clausen C, Goligorsky MS. Ionic currents and endothelin signaling in smooth muscle cells from rat renal resistance arteries. Am J Physiol 1994;266:F325-F341.
37. + current in arterial membranes from genetically hypertensive rats. Am J Physiol. 1993;264:H1337-H1345.
38. Galvez A, Gimenez-Gallego G, Reuben JP, Roy-Contancin L, Feigenbaum P, Kaczorowski GJ, Garcia ML. Purification of a unique potent peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamulus. J Biol Chem. 1990;265:11084-11090.
39. Langton PD, Nelson MT, Huang Y, Standen NB. Block of calcium-activated potassium channels in mammalian arterial myocytes by tetraethylammonium ions. Am J Physiol. 1991;29:H927-H934.
40. +. J Physiol. 1996;495:701-716.
41. Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K, Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4] oxadiazolo [4,3,-a] quinoxalin-1-one. Mol Pharmacol. 1995;48:184-188.
42. Zou AP, Ma YH, Sui ZH, Ortiz de Montellano PR, Clark JE, Masters BS, Roman RJ. Effects of 17-octadecynoic acid, a suicide-substrate inhibitor of cytochrome P450 fatty acid ω-hydroxylase, on renal function of rats. J Pharmacol Exp Ther. 1994;268:474-481.
43. Ma YH, Gebremedhin D, Schwartzman ML, Falk JR, Clark JE, Masters BS, Harder DR, Roman RJ. 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries. Circ Res. 1993; 72:126-136.
44. Glantz SA. Primer of Biostatistics. 2nd ed. New York, NY: McGraw-Hill Book Co; 1987.
45. O'Keeffe DH, Ebel RE, Peterson JA. Studies of the oxygen binding site of cytochrome P-450. Nitric oxide as a spin-label probe. J Biol Chem. 1978;253:3509-3516.
46. Giangiacomo KM, Garcia ML, McManus O. Mechanism of iberiotoxin block of the large-conductance calcium-activated potassium channel from bovine aortic smooth muscle. Biochemistry. 1991;31:6719-6727.
47. 2+ channels. J Neurosci Res. 1996;45:216-225.
48. 2+ channels by S-nitrosothiol nitric oxide donors. Circ Res. 1997;81:742-752.
49. 2+ in vascular smooth muscle by inhibition of the calcium current. Cell Calcium. 1994;15: 122-131.
50. 2+ currents in alveolar epithelial cells. Am J Physiol 1997;272:L1092-L1097.
51. Imig JD, Zou AP, Stec DE, Harder DR, Falck JR, Roman RJ. Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. Am J Physiol. 1996;270:R217-R227.
52. Zou AP, Cowley AW Jr. Nitric oxide in the renal cortex and medulla. An in vivo microdialysis study. Hypertension. 1997;27:194-198.
53. Cohen RA, Plane F, Najibi S, Huk I, Malinski T, Garland CJ. Nitric oxide is the mediator of both endothelium-dependent relaxation and hyperpolarization of the rabbit carotid artery. Proc Natl Acad Sci U S A. 1997; 94:4193-4198.